6Green TD, Montefiori DC, Ross TM. Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d. J Virol, 2003, 77(3): 2046-2055.
2Harford.J.,1999, Corporate Cash Reserves and Acquisitions,Journal of Finance54,1969-1997
3Opler, T.,L.Pinkowitz,R.Stulz, and R.Williamson, 1999, The Determinants and Implications of Corporate Cash Holdings Journal of Financial Economics52,3-46
4Jensen,M.C.,1986,Agency Costs of Free Cash Flow,Corporate Finance and Takeovers, American Economic Review